Latest news and press releases about Accuray Incorporated (ARAY): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Accuray Incorporated specializes in the design, development, production, and sale of advanced radiosurgery and radiation therapy equipment aimed at treating tumors. Their market footprint spans across North and South America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and the broader Asia Pacific region.
Price
| Price | $0.24 |
| Market Cap | $29M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.67 |
| EV / EBITDA | -12.16 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -99.04% |
| Return on Invested Capital | -10.09% |
| Return on Assets | -11.09% |
| Gross Margin | 27.73% |
| Operating Margin | -6.58% |
| Net Margin | -12.24% |
Related companies: ANIK · AVR · LNSR · MIST · MXCT · OWLT · PROF
Explore sector: Healthcare · Medical - Devices
More sections of ARAY: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks